發(fā)布時間：2019-02-13 09:31

【摘要】：目的檢測視網(wǎng)膜靜脈阻塞(retinal vein occlusion,RVO)患者的同型半胱氨酸(homocysteine,Hcy)水平和血小板參數(shù),包括血小板計數(shù)(platelet,PLT)、血小板平均體積(mean platelet volume,MPV),探討兩者是否作為致病因素參與RVO發(fā)病。方法對臨床診斷為RVO的48例患者(RVO組)進行血PLT、MPV、Hcy測定,包括視網(wǎng)膜分支靜脈阻塞(branch retinal vein occlusion,BRVO)患者22例(BRVO組)和視網(wǎng)膜中央靜脈阻塞(central retinal vein occlusion,CRVO)患者26例(CRVO組),并與臨床診斷為白內障的40例對照組進行比較并作統(tǒng)計學分析。結果 RVO組PLT水平(212.99±50.10)×10~9L~(-1),與對照組PLT水平(198.11±44.69)×10~9L~(-1)比較,差異無統(tǒng)計學意義(P0.05),RVO組MPV與Hcy水平(9.44±0.97)f L、(8.99±0.81)μmol·L~(-1)較對照組(8.66±0.96)f L和(8.38±0.62)μmol·L~(-1)均增高(均為P0.05)。PLT水平在CRVO組(212.27±49.07)×10~9L~(-1)、BRVO組(213.84±52.43)×10~9L~(-1)及對照組間比較差異均無統(tǒng)計學意義(均為P0.05),MPV、Hcy水平在CRVO組(9.48±0.91)f L、(8.97±0.76)μmol·L~(-1)與BRVO組(9.40±1.06)f L、(9.01±0.89)μmol·L~(-1),較對照組均增高(均為P0.05),但在CRVO組與BRVO組間比較差異均無統(tǒng)計學意義(均為P0.05)。結論高MPV、高Hcy可能是引起RVO發(fā)病的危險因素,降血小板及降Hcy的治療從理論上講是一種積極有效的預防措施。
[Abstract]:Objective to detect the levels of homocysteine (homocysteine,Hcy) and platelet parameters, including platelet count (platelet,PLT) and mean platelet volume (mean platelet volume,MPV) in patients with retinal vein occlusion (retinal vein occlusion,RVO). To explore whether the two factors play a role in the pathogenesis of RVO. Methods Blood PLT,MPV,Hcy was measured in 48 patients with RVO (RVO group), including 22 patients with retinal branch vein occlusion (branch retinal vein occlusion,BRVO) and (central retinal vein occlusion, with central retinal vein occlusion (BRVO group). 26 cases of CRVO (CRVO group) were compared with 40 cases of control group. Results the level of PLT in RVO group was (212.99 鹵50.10) 脳 10 ~ (-9) L ~ (-1), and the level of PLT was (198.11 鹵44.69) 脳 10 ~ (9) L ~ (-1) in RVO group. There was no significant difference (P0.05) between MPV and Hcy in), RVO group (9.44 鹵0.97) f L,). The level of (8.99 鹵0.81) 渭 mol L ~ (-1) in CRVO group was significantly higher than that in control group (8.66 鹵0.96) f L and (8.38 鹵0.62) 渭 mol L ~ (-1) (P0.05). PLT) in CRVO group (212.27 鹵49.07) 脳 10 ~ (9) L ~ (-1). There was no significant difference between BRVO group (213.84 鹵52.43) 脳 10 ~ (9) L ~ (-1) and control group (P0.05), and MPV,Hcy level was (9.48 鹵0.91) f L, in CRVO group. (8.97 鹵0.76) 渭 mol L ~ (-1) and BRVO (9.40 鹵1.06) f L, (9.01 鹵0.89) 渭 mol L ~ (-1), which were higher than those in the control group (P0.05). But there was no significant difference between CRVO group and BRVO group (P0.05). Conclusion High MPV, and high Hcy may be the risk factors of RVO. The treatment of decreasing platelet and decreasing Hcy is an active and effective preventive measure in theory.
【作者單位】： 錦州醫(yī)科大學;錦州醫(yī)科大學附屬第一醫(yī)院眼科;
【分類號】：R774.1

【相似文獻】

相關期刊論文 前10條

1 肖屏風;中西醫(yī)結合治療視網(wǎng)膜靜脈阻塞24例[J];湖南中醫(yī)雜志;2000年03期

2 吳健梅;中西醫(yī)結合治療視網(wǎng)膜靜脈阻塞27例[J];河南中醫(yī);2000年05期

3 盧寧,李志輝;視網(wǎng)膜靜脈阻塞治療新方法的實驗和臨床研究[J];國外醫(yī)學.眼科學分冊;2001年02期

4 萬素萍;中西醫(yī)結合治療視網(wǎng)膜靜脈阻塞29例[J];湖南中醫(yī)雜志;2002年05期

5 錢志成,黃彩英;中西醫(yī)藥辨治視網(wǎng)膜靜脈阻塞[J];天津藥學;2002年06期

6 于俊利,趙志凜;兩種不同方法治療視網(wǎng)膜靜脈阻塞療效分析[J];臨床眼科雜志;2003年01期

7 張曉湄,何劍峰;視網(wǎng)膜靜脈阻塞的研究進展[J];臨床眼科雜志;2003年02期

8 程慧君,詹宇堅;視網(wǎng)膜靜脈阻塞的療效及機理研究進展[J];中國中醫(yī)眼科雜志;2003年04期

9 周平,區(qū)顯寧,周衛(wèi)為;氪激光治療視網(wǎng)膜靜脈阻塞的療效評估[J];眼科新進展;2004年01期

10 孟根花,烏仁圖雅;視網(wǎng)膜靜脈阻塞的治療進展[J];內蒙古醫(yī)學雜志;2004年08期

相關會議論文 前10條

1 陳寶軍;;76例視網(wǎng)膜靜脈阻塞臨床治療觀察[A];浙江省中醫(yī)藥學會眼科分會2009繼續(xù)教育學習班論文集[C];2009年

2 姜虎林;楊雪萍;王淑靜;韓旭巍;楊超;;中西醫(yī)結合治療視網(wǎng)膜靜脈阻塞臨床觀察[A];第六屆全國中醫(yī)中西醫(yī)結合眼科學術交流會論文匯編[C];2007年

3 劉艷紅;申梨花;廖珊;王s闃，

本文編號：2421405